Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

The Erythropoietin Promoter Variant Rs1617640 is Not Associated with Severe Retinopathy of Prematurity, Independent of Treatment with Erythropoietin

Christof Dame,Lina K. Sciesielski, Carolin Rau,Chiara-Aiyleen Badur,Christoph Buehrer

˜The œjournal of pediatrics/˜The œJournal of pediatrics（2018）

Cited 8|Views11
No score
Abstract
In this case-control study, the erythropoietin (EPO) promoter variant s1617640, linked to high intravitreal EPO concentrations and increased risk of diabetic retinopathy, was not associated with severe retinopathy of prematurity. This finding was observed both in infants with and without recombinant EPO administration.
More
Translated text
Key words
ROP,EPO,PCR,rEPO,VLBW
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined